TWIG Therapeutics | B2B longevity products for global distribution
Licensing & Distribution

Partner With TWIG Therapeutics

TWIG is seeking qualified distributors, licensees, clinics, pharmacies, and healthcare channels for the Senolytics Protocol, with initial focus on Thailand and Colombia.

Available Product: TWIG Senolytics

A premium sachet-based senolytic protocol manufactured in California and packaged for professional B2B distribution.

  • 15 sachets per box
  • Three-month protocol per box
  • No direct consumer sales. TWIG works through authorized distributors and licensed market operators.
product

U.S.-Based Commercial Operations with California Manufacturing

Commercial Office

Miami Beach, Florida, USA

Manufacturing

Ontario, California, USA

Distributor Support

Product information, marketing materials, regulatory coordination, and launch planning support for qualified partners.

Regulatory Strategy

Regulatory registration, import permits, labeling compliance, language localization, and commercialization approvals are generally managed by the authorized distributor or licensee in each market.

Typical Launch Quantities

Market Evaluation

100–300 boxes

Clinic Launch

500–1,000 boxes

Regional Launch

2,000–5,000 boxes

National Launch

5,000–20,000 boxes

Exclusive Territory

20,000+ boxes annually

Actual quantities, pricing, licensing, territory rights, and regulatory responsibilities are determined through direct discussions with qualified distribution partners.

Distribution Partnership Inquiry

Submit your company information and estimated market development requirement. TWIG will review distributor qualifications, licensing needs, regulatory requirements, product availability, import/export restrictions, and pricing before confirming any commercial arrangement.